Home > Riviste > Minerva Endocrinologica > Fascicoli precedenti > Minerva Endocrinologica 2020 September;45(3) > Minerva Endocrinologica 2020 September;45(3):264-5

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo

 

LETTERS TO THE EDITOR   

Minerva Endocrinologica 2020 September;45(3):264-5

DOI: 10.23736/S0391-1977.20.03189-2

Copyright © 2020 EDIZIONI MINERVA MEDICA

lingua: Inglese

Tolvaptan efficacy and drug-drug interactions

Matteo PICCICA 1, Gregorio BASILE 1, Filippo BARTALESI 2, Gabriele PARENTI 3, Alberto FARESE 2, Lisa BUCI 3, Giampaolo CORTI 1, 2, Alessandro BARTOLONI 1, 2, Alessandro PERI 4

1 Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy; 2 Unit of Infectious and Tropical Diseases, Careggi University Hospital, Florence, Italy; 3 Unit of Pituitary Diseases and Sodium Alterations, Department of Endocrinology, Careggi University Hospital, Florence, Italy; 4 Pituitary Disease and Sodium Alterations Unit, Department of Endocrinology, University of Florence, AOU Careggi, Florence, Italy



inizio pagina